iANTHUS CAPITAL HOLDINGS (ITHUF) Income from Continuing Operations (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Income from Continuing Operations came in at 14309000.0 in Q1 2026, down 377.84% year-on-year from 5150000.0 in Q1 2025, and down 1.55% quarter-over-quarter from 14090000.0 in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Income from Continuing Operations (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Income from Continuing Operations across 7 years of filings, most recently posting 14309000.0 for Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 14309000.0, down 377.84% year-over-year; the trailing twelve-month figure through Mar 2026 was 59662000.0 (down 580.92% YoY), and the FY2025 annual result was 40203000.0, down 44.05% from the prior year.
- Income from Continuing Operations came in at 14309000.0 for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from 14090000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 7519000.0 in Q4 2024 to a low of 373562000.0 in Q2 2022.
- The 5-year median for Income from Continuing Operations is 14309000.0 (2026), against an average of 35790235.29.
- Across the five-year window, Income from Continuing Operations sank 2348.62% in 2022 and jumped 140.22% in 2024, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Income from Continuing Operations stood at 43732000.0 in 2022, then surged by 57.25% to 18695000.0 in 2023, then jumped by 140.22% to 7519000.0 in 2024, then slumped by 287.39% to 14090000.0 in 2025, then retreated by 1.55% to 14309000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 14309000.0 (Q1 2026), 14090000.0 (Q4 2025), and 12545000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | -14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.31 Mn |
| Dec 31, 2025 | -14.09 Mn |
| Sep 30, 2025 | -12.55 Mn |
| Jun 30, 2025 | -18.72 Mn |
| Mar 31, 2025 | 5.15 Mn |
| Dec 31, 2024 | 7.52 Mn |
| Sep 30, 2024 | -11.64 Mn |
| Jun 30, 2024 | -9.79 Mn |
| Mar 31, 2024 | -14.00 Mn |
| Dec 31, 2023 | -18.70 Mn |
| Sep 30, 2023 | -19.18 Mn |
| Jun 30, 2023 | -20.15 Mn |
| Mar 31, 2023 | -18.60 Mn |
| Dec 31, 2022 | -43.73 Mn |
| Sep 30, 2022 | -22.00 Mn |
| Jun 30, 2022 | -373.56 Mn |
| Mar 31, 2022 | -10.10 Mn |
| Dec 31, 2021 | -26.95 Mn |
| Sep 30, 2021 | -15.84 Mn |
| Jun 30, 2021 | -15.26 Mn |